REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro De Investigacion Y Tratamiento Neurologico Ltda Citen Ltda (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Centro De Investigacion Y Tratamiento Neurologico Ltda Citen Ltda Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Centro De Investigacion Y Tratamiento Neurologico Ltda Citen Ltda is an enterprise in Colombia, with the main office in Monteria. It operates in the Ambulatory Health Care Services industry. The company was established on March 24, 2004. The latest financial highlights indicate a net sales revenue increase of 16.84% in 2023. Its’ total assets recorded a growth of 22.78%. The net profit margin of Centro De Investigacion Y Tratamiento Neurologico Ltda Citen Ltda decreased by 3.14% in 2023.

Headquarters
Calle 35 14 18 Brr El Eden
Monteria; Cordoba;

Contact Details: Purchase the Centro De Investigacion Y Tratamiento Neurologico Ltda Citen Ltda report to view the information.

Basic Information
Outstanding Shares:
Purchase the Centro De Investigacion Y Tratamiento Neurologico Ltda Citen Ltda report to view the information.
Incorporation Date:
March 24, 2004
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Centro De Investigacion Y Tratamiento Neurologico Ltda Citen Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
16.84%
Total operating revenue
16.84%
Operating profit (EBIT)
-30.45%
EBITDA
-26.28%
Net Profit (Loss) for the Period
-16.56%
Total assets
22.78%
Total equity
4.48%
Operating Profit Margin (ROS)
-10.6%
Net Profit Margin
-3.14%
Return on Equity (ROE)
-5.08%
Debt to Equity Ratio
24.98%
Quick Ratio
-0.01%
Cash Ratio
0.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?